Florida expands its scope of opioid lawsuit to include CVS and Walgreens

Florida expanded the scope of its original opioid lawsuit to include two pharmacy giants, CVS and Walgreens. The original lawsuit was filed in the month of May and it included four durgmakers: Purdue Pharma, the maker of OxyContin; Janssen Pharmaceuticals, the maker of fentanyl drug Duragesic; Endo Pharmaceuticals, the maker of Percocet and Opana; and Teva Pharmaceutical, a drugmaker that makes generic versions of pain medications.

It is alleged that the two largest drugstore chains failed to stop suspicious orders of opioid and has dispensed unreasonable quantities of opioid from their pharmacies.

According to the complaint, CVS distributed 700 million opioid dosages in Florida between 2006 to 2014. In addition, one Walgreens distribution center supplied 285,800 orders of oxycodone in one month in a town with a population of just 3,000 people.

The lawsuit mentioned that the defendants have reaped billions of dollars in terms of revenue, while they were aware or should have been aware that they were causing immense harm to the state and its citizens.

Along with these measures, opioid addiction engagement and addiction engagement software are vital for combating opioid addiction crisis.